Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Blood
|
May 1, 1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia
E Archimbaud, V Leblond, M Michallet, et al.
La Revue De Medecine Interne
|
November 15, 2000
[Diagnosis of iron deficiency: evaluation of the "soluble transferrin receptor/transferrin" ratio]
M Ruivard, M Boursiac, G Mareynat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1995
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial
E Archimbaud, X Thomas, V Leblond, et al.
Leukemia & Lymphoma
|
November 1, 1994
The hematopoietic stem cell transplantation in Hodgkin's disease: questions and controversies
J Fleury, M Legros, H Cure, et al.
Leukemia & Lymphoma
|
June 1, 1992
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements
F Vuillier, J F Claisse, C Vandenvelde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
hTERT expression and prognosis in B-chronic lymphocytic leukemia
A Tchirkov, C Chaleteix, C Magnac, et al.
Leukemia Research
|
May 1, 1993
Lineage promiscuity in leukemia studies of T-cell receptor and immunoglobulin genes
D Bernard, Y J Bignon, F Lavenue, et al.
Leukemia
|
March 1, 1993
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia
E Archimbaud, P Fenaux, J Reiffers, et al.
Bulletin Du Cancer
|
July 1, 1994
[Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults]
J Fleury, J Tortochaux, M Legros, et al.
Annals of Hematology
|
February 9, 2000
Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells
P Halle, C Rouzier, J Kanold, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Blood
|
May 1, 1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia
E Archimbaud, V Leblond, M Michallet, et al.
La Revue De Medecine Interne
|
November 15, 2000
[Diagnosis of iron deficiency: evaluation of the "soluble transferrin receptor/transferrin" ratio]
M Ruivard, M Boursiac, G Mareynat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1995
Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial
E Archimbaud, X Thomas, V Leblond, et al.
Leukemia & Lymphoma
|
November 1, 1994
The hematopoietic stem cell transplantation in Hodgkin's disease: questions and controversies
J Fleury, M Legros, H Cure, et al.
Leukemia & Lymphoma
|
June 1, 1992
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements
F Vuillier, J F Claisse, C Vandenvelde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
hTERT expression and prognosis in B-chronic lymphocytic leukemia
A Tchirkov, C Chaleteix, C Magnac, et al.
Leukemia Research
|
May 1, 1993
Lineage promiscuity in leukemia studies of T-cell receptor and immunoglobulin genes
D Bernard, Y J Bignon, F Lavenue, et al.
Leukemia
|
March 1, 1993
Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia
E Archimbaud, P Fenaux, J Reiffers, et al.
Bulletin Du Cancer
|
July 1, 1994
[Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults]
J Fleury, J Tortochaux, M Legros, et al.
Annals of Hematology
|
February 9, 2000
Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells
P Halle, C Rouzier, J Kanold, et al.
Page
of 7